Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
- 1 May 2014
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 157 (5) , 1033-1037.e2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changesEye, 2013
- Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathyEye, 2012
- Functional Retinal Changes Measured by Microperimetry in Standard-Fluence vs Low-Fluence Photodynamic Therapy in Chronic Central Serous ChorioretinopathyAmerican Journal of Ophthalmology, 2011
- Standard-Fluence versus Low-Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Nonrandomized Clinical TrialAmerican Journal of Ophthalmology, 2010
- Posterior Cystoid Retinal Degeneration in Central Serous ChorioretinopathyRetina, 2008
- SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2008
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyBritish Journal of Ophthalmology, 2006
- The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathyAmerican Journal of Ophthalmology, 2005
- INDOCYANINE GREEN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2003
- Retinal atrophy in idiopathic central serous chorioretinopathyAmerican Journal of Ophthalmology, 2002